"10.1371_journal.pone.0107726","plos one","2014-09-24T00:00:00Z","Natalie J Gauld; Fiona S Kelly; Nahoko Kurosawa; Linda J M Bryant; Lynne M Emmerton; Stephen A Buetow","Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand; School of Pharmacy, University of Auckland, Auckland, New Zealand; Griffith Health Institute, Griffith University, Brisbane, Queensland, Australia; Hokkaido Pharmaceutical University School of Pharmacy, Otaru, Hokkaido, Japan; School of Pharmacy, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia","Conceived and designed the experiments: NG LB SB. Analyzed the data: NG NK LB FK LE. Wrote the paper: NG SB LE LB FK NK.","NG was a member of the Medicines Classification Committee of NZ (2004â€2009), consulted on switch for Pharmacybrands Ltd, Pharmacy Retailing Ltd, Perrigo UK, Novartis Consumer Health, and Douglas Pharmaceuticals Ltd, and conducted research for Roche Products (New Zealand) Ltd. NG received travel funding as an invited speaker at an Australian Self-Medication Industries conference. NK declares the following potential conflicts of interest: consultancy for Kaigen Pharma Co Ltd, Japan. The other authors have no conflicts of interest to declare. This does not alter adherence to PLOS ONE policies on sharing data and materials.","2014","09","Natalie J Gauld","NJG",6,TRUE,3,NA,5,6,TRUE,TRUE,FALSE,0,NA,FALSE
